Liverpool Good Clinical Practice Laboratory
Our key objective is the acquisition, storage and analysis of high quality human biological samples for the purposes of research.
Good Clinical Practice (GCP) Laboratories work to defined quality standards which incorporates the regulatory requirements of GCP. Our is aim to produce transparent, reliable, reproducible results whilst also giving traceability, audit-ability and accountability.
The Liverpool Good Clinical Practice Laboratory Facility has a crucial role in supporting the International Severe Acute Respiratory and Emerging Infection Consortium - Coronavirus Clinical Characterisation Consortium (ISARIC-4C), in particular with the Clinical Characterisation Protocol (CCP).
The GCP Laboratory was established in 2009 and is affiliated with the Liverpool Clinical Trials Centre and are part of the Experimental Cancer Medicine Centres (ECMC) network
Advancing experimental cancer medicine
The ECMC network was launched in 2007 through a joint investment from Cancer Research UK, the National Institute for Health Research in England, and the Health Departments for Scotland, Wales, and Northern Ireland. Since then more than £70 million of ECMC funding has been supporting staff members across the UK. To find out more about Liverpool’s early phase cancer studies.